Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - VNUS Medical Technologies makes appointment:

This article was originally published in Clinica

Executive Summary

Peter Osborne, who was appointed as interim CFO of VNUS Medical Technologies (San Jose, California) in October 2007, will remain in the position on a permanent basis and also becomes the vice-president of finance and administration. Mr Osborne is a former audit partner of Deloitte & Touche and has more than 25 years' executive financial experience. VNUS is a developer of devices for the minimally-invasive treatment of venous reflux disease.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT045873

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel